Millavelez, Cris .
HRN: 28-85-44 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2026
CEFUROXIME 750MG (VIAL)
04/13/2026
04/19/2026
IV
750mg
Q12
UTI
Checking Initial Appropriateness
04/17/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/17/2026
04/24/2026
PO
4ml
BID
UTI
Checking Initial Appropriateness
04/20/2026
MUPIROCIN 2%, 15G (TUBE)
04/20/2026
04/27/2026
TOPICAL
As Needed
Q 12
Phlebitis
Checking Initial Appropriateness